- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The main objective of the trial is to demonstrate the pharmacodynamic equivalence of triptorelin pamoate (Pamorelin® LA 11.25 mg), applied either IM or SC, in terms of the area under the curve [AUC1-85d] for serum testosterone in patients with advanced prostate cancer.
Critère d'inclusion
- advanced prostate cancer (locally advanced or metastatic)